secwatch.observer — SEC 8-K summary
======================================

Issuer:     AbbVie Inc. (ABBV)
CIK:        0001551152
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001104659-25-017490
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AbbVie closes $4.0B senior notes offering across four maturities
----------------------------------------------------------------

- Closed $4.0B debt offering: $1.25B 4.650% notes due 2028, $1B 4.875% notes due 2030, $1B 5.200% notes due 2035, $750M 5.600% notes due 2055.
- Notes are unsecured, unsubordinated obligations ranking equally with existing and future unsecured debt.
- AbbVie may redeem notes at par after certain dates: 2028 notes after Feb 15, 2028; 2030 after Feb 15, 2030; 2035 after Dec 15, 2034; 2055 after Sep 15, 2054.
- Proceeds not specified; offering registered under Form S-3ASR filed Feb 14, 2025, prospectus supplement dated Feb 18, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/0001104659-25-017490-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1551152/000110465925017490/tm255723d7_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-017490

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer